Lineage Cell Therapeutics Reports Q3 2024 Highlights | Nasdaq
2 days ago · Lineage Cell Therapeutics, Inc. ( (LCTX)) has released its Q3 earnings. Here is a breakdown of the information Lineage Cell Therapeutics, Inc. presented to its investors. …
OFF
Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates
1 week from now
Lineage Cell (LCTX) delivered earnings and revenue surprises of 50% and 222.99%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the …
nasdaq.com
OFF
Panbela Provides Business Update And Reports Q3 2024 Financial …
1 week from now
2 days ago · Up to $12.0 million financing commitment secured from strategic investor, Nant Capital. First patient enrolled in a Phase I dose escalation study to evaluate CPP-1X-S in …
nasdaq.com
OFF
Allarity Therapeutics Reports Third Quarter 2024 Financial Results …
1 week from now
3 days ago · Third Quarter 2024 Financial Highlights Cash Position: As of September 30, 2024, Allarity had cash and cash equivalents of $18.5 million, compared to $0.2 million at December …
businessinsider.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
